These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6759713)

  • 1. [Liver cirrhosis].
    Hirayama C; Kawasaki H; Murawaki Y
    Nihon Rinsho; 1982; 40(9):2011-6. PubMed ID: 6759713
    [No Abstract]   [Full Text] [Related]  

  • 2. [The hepatorenal syndrome].
    Kramer HJ
    Z Gastroenterol Verh; 1986 Apr; 21():15-20. PubMed ID: 2422831
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatorenal disorders: role of the renin-angiotensin-aldosterone system.
    Bernardi M; Trevisani F; Gasbarrini A; Gasbarrini G
    Semin Liver Dis; 1994 Feb; 14(1):23-34. PubMed ID: 8016659
    [No Abstract]   [Full Text] [Related]  

  • 4. [Functional relations between liver and kidney. I. Sodium excretion].
    Köhler H; Meyer zum Büschenfelde KH
    Dtsch Med Wochenschr; 1988 Sep; 113(38):1486-91. PubMed ID: 2971522
    [No Abstract]   [Full Text] [Related]  

  • 5. [Liver cirrhosis and the renin-angiotensin-aldosterone system].
    Lozano de León F; Leal M; Lissen E
    Rev Esp Enferm Apar Dig; 1986 Nov; 70(5):465-8. PubMed ID: 3797771
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of valsartan, an angiotensin II receptor antagonist, on portal and systemic hemodynamics and on renal function in liver cirrhosis.
    Fierbinteanu-Braticevici C; Dragomir P; Tribus L; Negreanu L; Bengus A; Usvat R; Andronescu D
    J Gastrointestin Liver Dis; 2006 Dec; 15(4):337-42. PubMed ID: 17205144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of single dose of 50mg captopril in patients with liver cirrhosis and ascites.
    Lee JK; Hsieh JF; Tsai SC; Ho YJ; Kao CH
    Hepatogastroenterology; 2000; 47(33):767-70. PubMed ID: 10919029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current theories on the hepatorenal syndrome].
    Mysliwiec M; Myśliwiec B
    Przegl Lek; 1983; 40(9):689-92. PubMed ID: 6364259
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetic-hemodynamic interactions in cirrhosis.
    Blei AT
    Semin Liver Dis; 1986 Nov; 6(4):299-308. PubMed ID: 3544223
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prostaglandins and renal function in patients with liver cirrhosis].
    Markov KhM; Markova MN
    Urol Nefrol (Mosk); 1982; (4):63-8. PubMed ID: 6753299
    [No Abstract]   [Full Text] [Related]  

  • 11. [Relations between hepatic blood flow, general hemodynamics and temperature of the liver in liver cirrhosis].
    Vorob'ev LP; Maev IV; Andreev NG
    Sov Med; 1991; (2):70-2. PubMed ID: 2057848
    [No Abstract]   [Full Text] [Related]  

  • 12. Hemodynamics in the isolated cirrhotic liver.
    Zipprich A
    J Clin Gastroenterol; 2007; 41 Suppl 3():S254-8. PubMed ID: 17975473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Systemic hemodynamic imbalance in liver cirrhosis].
    Prieto J; Quiroga J; Aliaga L; Zozaya JM
    Rev Clin Esp; 1989 Jan; 184(1):1-2. PubMed ID: 2649942
    [No Abstract]   [Full Text] [Related]  

  • 14. [Changes in renal function and the intracellular environment in cirrhotic patients].
    Tiberio López G; Tanco S; Orradre B; Berrade MF; Anderiz López M
    Rev Esp Enferm Apar Dig; 1985 Apr; 67(4):367-78. PubMed ID: 2988084
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal failure in advanced liver disease.
    Baldus WP
    Prog Liver Dis; 1972; 4():251-67. PubMed ID: 4347066
    [No Abstract]   [Full Text] [Related]  

  • 16. [Our 2-year experience with the reinfusion of concentrated ascitic fluid in liver cirrhosis with emphasis on the hemodynamic effects of the renin-angiotensin-aldosterone system].
    Cervinka J; Benes R; Kordac V; Horký K
    Cas Lek Cesk; 1984 Apr; 123(16):482-4. PubMed ID: 6733746
    [No Abstract]   [Full Text] [Related]  

  • 17. Inappropriately low angiotensin II generation: a factor determining reduced kidney function and survival in patients with decompensated cirrhosis.
    Sansoé G; Silvano S; Mengozzi G; Todros L; Smedile A; Touscoz G; Rosina F; Rizzetto M
    J Hepatol; 2004 Mar; 40(3):417-23. PubMed ID: 15123355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Renal insufficiency in decompensated liver cirrhosis. Report of 5 cases and a review of the pathophysiology].
    Thomsen AC
    Ugeskr Laeger; 1968 Apr; 130(14):585-91. PubMed ID: 4303382
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hyperaldosteronism, spironolactone and liver cirrhosis].
    Sort P; Guevara M; Arroyo V
    Gastroenterol Hepatol; 1997 Mar; 20(3):151-9. PubMed ID: 9162537
    [No Abstract]   [Full Text] [Related]  

  • 20. [Renal perfusion and the renin-angiotensin system in hepatic cirrhosis].
    Bosch Y; Arroyo V; Mauri M; Rivera F; Rodes J
    Minerva Med; 1978 Oct; 69(47):3249-55. PubMed ID: 714306
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.